Willow Biosciences Inc. (CANSF)
- Previous Close
0.0172 - Open
0.0094 - Bid 0.0175 x --
- Ask 0.0200 x --
- Day's Range
0.0094 - 0.0200 - 52 Week Range
0.0030 - 0.1000 - Volume
222,000 - Avg. Volume
44,275 - Market Cap (intraday)
3.119M - Beta (5Y Monthly) 1.40
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
www.willowbio.com19
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CANSF
View More
Performance Overview: CANSF
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CANSF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CANSF
View MoreValuation Measures
Market Cap
3.16M
Enterprise Value
4.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.69
Price/Book (mrq)
--
Enterprise Value/Revenue
1.28
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-132.75%
Return on Assets (ttm)
-76.14%
Return on Equity (ttm)
-422.31%
Revenue (ttm)
4.66M
Net Income Avi to Common (ttm)
-6.19M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
353k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.35M